PCSK9 inhibition: Novel insights into a new therapeutic approach for the lowering of LDL-C: the PCSK9 saga
10' education - Sep. 3, 2014Lecture by Prof. Evan Stein, Amsterdam, Cincinnati, OH, USA held during EBAC accredited symposium 'Innovations in lipid management: Evolving insights and implications from PCSK9 research' held during ESC2014 in Barcelona
Educational information
The programme was CME accredited by EBAC